Genuine Bms-303141, Atp Citrate Lyase (acl) Inhibitor (tbi1414) Special: 30% Discount [ei2y8DPc]

BMS-303141: ATP Citrate Lyase Inhibitor (TBI1414)

BMS-303141, also known as TBI1414, is a highly potent and selective ATP citrate lyase (ACL) inhibitor. With an IC50 value of just 0.13 μM, it effectively inhibits ACL, which is crucial in lipid biosynthesis. This innovative compound offers a novel approach to combating metabolic disorders such as obesity and dyslipidemia. Below are some of its key features:

• Purity: BMS-303141 boasts an impressive purity level of >98%, ensuring reliable and consistent results.
• Formulation: Available as a powder, this inhibitor is easy to handle and integrate into various applications.
• Solubility: BMS-303141 is soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 20 mg/ml with warming), making it versatile for different experimental setups.

Product Benefits and Applications

BMS-303141 is not just a potent ACL inhibitor; it offers numerous practical applications. Here are some of its key benefits:

• Metabolic Disorders: BMS-303141 has been shown to reduce weight gain, lower plasma cholesterol, triglycerides, and glucose in high-fat-fed mice, making it a promising tool for studying and treating metabolic disorders.
• Cancer Research: The compound has demonstrated the ability to impair proliferation or induce death in androgen-depleted castration-resistant prostate cancer cells, offering potential for cancer research and treatment.
• Cell Cycle Progression: BMS-303141 also reduces cell cycle progression in iBN cells, further highlighting its versatility in various research applications.

With its exceptional purity, ease of use, and wide range of applications, BMS-303141 is an invaluable tool for researchers and scientists seeking to explore the potential of ACL inhibition in metabolic disorders and cancer research.